How the brain's natural opioids in the midbrain influence motivation
Investigating non-canonical mechanisms of endogenous opioids on motivation in dorsal midbrain
This project looks at whether natural opioid chemicals in a part of the midbrain change motivation and mood to help people with low motivation or mood disorders.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11301827 on NIH RePORTER |
What this research studies
From a patient's perspective, researchers are mapping how the brain's own opioid signals in small dorsal midbrain regions affect motivated behaviors. They will combine animal experiments, targeted molecular tools (including CRISPR-Cas9 to reduce opioid peptides), neural recordings, and computational modeling to link specific circuits to behavior. Prior work shows nearby midbrain sites can both boost and suppress appetite and motivation, and this project aims to clarify those opposing roles. The long-term goal is to point toward new targets for treatments of mood and motivational problems.
Who could benefit from this research
Good fit: Adults with depression, low motivation, or other affective disorders would be the most relevant candidates for future trials or follow-up studies based on these findings.
Not a fit: People without mood or motivation symptoms, or those seeking immediate clinical treatment, are unlikely to receive direct benefit from this basic research.
Why it matters
Potential benefit: If successful, this work could reveal new brain targets for therapies that better restore motivation and mood in people with affective disorders.
How similar studies have performed: Previous animal studies and pilot experiments (including opioid microinjections and CRISPR-based knockdown) have shown midbrain opioid signals can alter appetite and motivation, but the specific non-canonical mechanisms here are relatively new.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Castro, Daniel Charles — Washington University
- Study coordinator: Castro, Daniel Charles
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.